Abstract
Sleep is essential for physical and mental health, yet large-scale assessment of sleep stages and sleep apnea is limited by the cost and burden of clinical polysomnography. Wrist accelerometry provides a scalable lower-fidelity alternative, but its usefulness is highly reliant on modeling choices. Generative self-supervised learning has remained unexplored for this purpose. To address this, we developed and pretrained physiology-aware masked autoencoders to capture pulse-and respiration-related motion using ∼700,000 days of wrist accelerometry from 108,904 recordings in the UK Biobank cohort. This effort culminated in AcceleRest, a transformer model pretrained using a respiratory amplification objective. Performance was validated against polysomnography across 478 recordings from six cohorts and devices including independent external test cohorts. AcceleRest feature vectors enabled linear wake–NREM–REM sleep staging with a macro F1 score of 0.69 and respiratory event detection with a macro F1 of 0.56. The combined model outputs enabled sleep apnea severity evaluation with a 67% sensitivity and 96% specificity for severe apnea. Overall agreement between polysomnography and AcceleRest showed a bias of 0.8 min for total sleep duration, with 95% limits of agreement (LoA) of –101.6 to 103.2 min, and 32.5 min for REM sleep duration and 95% LoA of –68.7 to 133.6 min. These findings demonstrate that physiology-aware pretraining can enable robust and clinically meaningful sleep phenotyping from wrist accelerometers, supporting scalable screening and longitudinal monitoring of sleep health. To the best of our knowledge, AcceleRest represents the first wrist accelerometry model for joint sleep stage and apnea evaluation. All code and models will be made available upon final peer-reviewed publication.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding was received for this study.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This project was approved by Stanford University IRB under protocol ID 72475.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Access to the UK Biobank data can be obtained by application. The data for the Newcastle cohort can be downloaded at https://zenodo.org/records/1160410#.Y-O65i-l1qs. Data from the DREAMT cohort can be downloaded at: https://physionet.org/content/dreamt/2.1.0/ Access to data from the remaining cohorts can be requested by contacting the corresponding institutes.
